← Eichor
Study identifier: NCT06623461 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Condition: Melanoma  ·  Sponsor: Canadian Cancer Trials Group

PhasePhase 2
Planned participants128
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is being done to answer the following question: Can the chance of melanoma growing or spreading be lowered by receiving a treatment called LND101 for Fecal Microbiota Transplant (FMT) in addition to the usual immunotherapy treatment called Immune Checkpoint Blockade (ICB)? FMT treatment changes the bacteria in your gut called the microbiome.

This description comes directly from the study's public registry record.

Talk to the study team

Janet Dancey  ·  613-533-6430  ·  jdancey@ctg.queensu.cca

Always discuss trial participation with your own doctor first.

Locations (14)

BCCA - AbbotsfordAbbotsford British Columbia, British Columbia, CanadaRecruiting
BCCA - SurreySurrey, British Columbia, CanadaRecruiting
BCCA - VancouverVancouver, British Columbia, CanadaRecruiting
Juravinski Cancer Centre at Hamilton Health SciencesHamilton, Ontario, CanadaRecruiting
London Health Sciences Centre Research Inc.London, Ontario, CanadaRecruiting
Stronach Regional Health Centre at SouthlakeNewmarket, Ontario, CanadaRecruiting
Ottawa Hospital Research InstituteOttawa, Ontario, CanadaRecruiting
Odette Cancer CentreToronto, Ontario, CanadaRecruiting
University Health NetworkToronto, Ontario, CanadaRecruiting
Centre Integre de Sante et de Services SociauxGreenfield Park, Quebec, CanadaRecruiting
CHUM-Centre Hospitalier de l'Universite de MontrealMontreal, Quebec, CanadaRecruiting
The Jewish General HospitalMontreal, Quebec, CanadaRecruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06623461